NRX PharmaceuticalsNRXP
13F holders, Q1 2024 (March 31)31holders
1famous investor
$0.47avg. 13F price*
At the end of Q1 2024, 31 institutions reported holding NRX Pharmaceuticals Inc. (NRXP) in their 13F filings. The largest holders were Vanguard Group Inc. ($680K), AdvisorShares Investments LLC ($290K) and Geode Capital Management, LLC ($198K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- NRX Pharmaceuticals Inc.
- CUSIP
- 629444100
- Latest filing quarter
- Q1 2024
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $32K |
| Exits | 3 | $36K |
Ownership 31 holders
| Vanguard Group Inc. | 0.00% | Reduce -0.4% | 1,440,045 | $680K |
| AdvisorShares Investments LLC | 0.05% | Reduce -4.3% | 614,793 | $290K |
| Geode Capital Management, LLC | 0.00% | Add +1.9% | 419,954 | $198K |
| BlackRock Inc. | 0.00% | No change | 290,714 | $137K |
| Renaissance Technologies | 0.00% | Reduce -5.8% | 188,780 | $89K |
| One Wealth Management Investment & Advisory Services, LLC | 0.03% | No change | 140,402 | $66K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 122,700 | $58K |
| State Street Corp. | 0.00% | No change | 114,240 | $54K |
| Northern Trust Corp. | 0.00% | No change | 74,996 | $35K |
| Texas Capital Bank Wealth Management Services Inc | 0.00% | No change | 63,290 | $30K |
| Morgan Stanley | 0.00% | Reduce -0.9% | 43,948 | $21K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 43,732 | $21K |
| XTX Topco Ltd | 0.00% | New | 39,396 | $19K |
| Jane Street Group, LLC | 0.00% | New | 27,685 | $13K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +8.8% | 21,426 | $10K |
| United Asset Strategies, Inc. | 0.00% | No change | 18,300 | $9K |
| UBS Group AG | 0.00% | Reduce -64.6% | 16,571 | $8K |
| LPL Financial LLC | 0.00% | No change | 14,568 | $7K |
| Bank of New York Mellon Corp | 0.00% | No change | 10,129 | $5K |
| Ieq Capital, LLC | 0.00% | No change | 10,000 | $5K |
| NewEdge Advisors, LLC | 0.00% | Reduce -18.3% | 5,825 | $3K |
| Wells Fargo & Company | 0.00% | Add +0.2% | 5,429 | $3K |
| Cutler Group LLC / CA | 0.00% | No change | 3,220 | $1K |
| Osaic Holdings, Inc. | 0.00% | No change | 1,000 | $472 |
| Group One Trading LLC | 0.00% | Reduce -95.3% | 907 | $428 |
| JPMorgan Chase & Co. | 0.00% | Reduce -97.1% | 492 | $232 |
| Larson Financial Group LLC | 0.00% | No change | 218 | $103 |
| Qube Research & Technologies Ltd | 0.00% | No change | 165 | $78 |
| FMR LLC | 0.00% | New | 110 | $52 |
| Royal Bank of Canada | 0.00% | Reduce -99.9% | 125 | $0 |
| Simplex Trading, LLC | 0.00% | New | 195 | $0 |
"% of holder's portfolio" is NRXP's weight in each manager's 13F, not the share of NRX Pharmaceuticals Inc. the manager owns.